Please login to the form below

Not currently logged in
Email:
Password:

pricing

This page shows the latest pricing news and features for those working in and with pharma, biotech and healthcare.

First Humira biosimilars reach EU market

First Humira biosimilars reach EU market

There’s no official word on pricing yet from any company, but Sandoz predicts that use of its drug could cut the NHS’annual £500m ($658m) bill for Humira in half.

Latest news

More from news
Approximately 94 fully matching, plus 848 partially matching documents found.

Latest Intelligence

  • Made in China Made in China

    We are now seeing pricing of medicines within the same range as Europe.”.

  • Brand teams: why are some smarter than others? Brand teams: why are some smarter than others?

    The consequences of this can be seen in launches that fail to meet expectations and pricing pressures that overwhelm brand preference.

  • Trust me, I’m from pharma Trust me, I’m from pharma

    However, controversies around drug pricing – fuelled by the unhelpful interventions of Martin Shkreli as the pin-up boy for big, bad pharma – have undermined progress and reinforced the view that the

  • Bluebird Bio: on the cusp of a gene therapy revolution Bluebird Bio: on the cusp of a gene therapy revolution

    success. Europe has already seen two gene therapies approved but fail commercially – UniQure’s Glybera and GSK’s Strimvelis – and so Bluebird has to learn lessons on pricing and reimbursement and ... It was also held back by huge bureaucracy

  • Happy 70th birthday NHS: the next 70 need to be very different Happy 70th birthday NHS: the next 70 need to be very different

    The pharmaceutical industry produced a clear example of this, with Vertex spoiling the birthday party mood by saying it was “outrageous”that NHS England has not accepted its latest pricing and ... Nevertheless this year is a crucial one, with three

More from intelligence
Approximately 16 fully matching, plus 143 partially matching documents found.

Latest appointments

  • BMS appoints CCO, Stephen Davies joins Eisai and more BMS appoints CCO, Stephen Davies joins Eisai and more

    She will also oversee marketing, pricing, forecasting and analytics. Brian Hoffmann, president of Hikma’s generics division, said: “I am looking forward to working closely with Kristy and her team to

  • Weekly comms appointments Weekly comms appointments

    Pyati’s new domain will see him grow and expand the group’s scientific and medical communications practice and integrating it with the firm’s analytics, digital and value, pricing and

  • Claes Buxfeldt joins NDA Claes Buxfeldt joins NDA

    He has represented the payer voice in development programmes including the development of payer evidence strategies, pricing, market access strategy, economic models and clinical programme input.

  • Mereo BioPharma appoints head of patient access and commercial planning Mereo BioPharma appoints head of patient access and commercial planning

    In this role, Hughes-Wilson was responsible for Sobi’s commercialisation approach and led pricing, reimbursement and access teams for the group’s rare disease product portfolio.

  • W2O bolsters its commercialisation offering W2O bolsters its commercialisation offering

    W2O bolsters its commercialisation offering. Rita Glaze joins the firm as leader of value, pricing and market access practice. ... Glaze has 25 years’experience in the biopharmaceutical and life science sector with expertise in marketing, managed

More from appointments
Approximately 2 fully matching, plus 28 partially matching documents found.

Latest from PMHub

  • PRMA Consulting Ltd

    PRMA Consulting Ltd. PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international pharmaceutical and biotechnology companies today. ... Our tailored services

  • Valid Insight

    With a team that includes some of the world’ s leading market access and pricing experts, our clients trust us to help them navigate through the most challenging environments. ... We focus on pricing, market access and value communication strategy

  • Remap Consulting

    Remap Consulting. Remap Consulting is a specialist pharmaceutical pricing and market access consultancy. ... Our mission is to help solve your pricing and market access challenges to ensure improved patient access to your products.

  • Organisational Memory

    Then, a whole swathe of people are needed to get the product onto the market in the first place: pricing and reimbursement experts, government affairs, public relations people, and patient relations

  • When data are not enough...

    support premium pricing. increase the impact of promotional efforts. achieve product loyalty.

More from PMHub
Approximately 6 fully matching, plus 53 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...
Ali Frederic Ben-Amor
Tackling a formidable foe
Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...
Geoff
Cancer care – the power of new technologies
With patient numbers set to soar, how can we make a difference?...

Infographics